journal article·2026-01-16

Surface Engineering of Carbon Nano-Onions for Folic Acid-Mediated Targeted Chemotherapeutic Delivery

Michał Bartkowski, Yingru Zhou, Ilaria Penna, Debora Russo, Hugh Mohan, Tiago Serodre, Eric Anglaret, Tiziano Bandiera, Silvia Giordani

ACS Applied Nano Materials· Volume 9· Issue 2
Publisher page

Abstract

Carbon nano-onions (CNOs) are an emerging class of carbon nanomaterials with distinctive physicochemical properties, including small size, high surface area, and favorable biocompatibility. Their multilayered carbon structure and accessible surface chemistry make them attractive candidates for functional nanomaterials in biomedical applications. In this work, we report the synthesis and functionalization of CNOs with folic acid (FA) to achieve receptor-mediated targeting of cancer cells overexpressing folate receptors. The FA-modified CNOs were further engineered for the efficient loading and controlled release of doxorubicin (DOX). Surface modifications were confirmed by a comprehensive suite of spectroscopic, microscopic, and thermal characterization techniques, which verified successful FA conjugation and drug incorporation. In vitro assays demonstrated that FA-functionalized CNOs significantly enhance cellular uptake and drug delivery efficiency compared to nontargeted controls. These results not only validate FA-CNOs as potential nanocarriers for cancer therapy but also underscore the versatility of CNOs as a tunable carbon nanomaterial platform for targeted delivery applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Carbon and Quantum Dots Applications · Graphene and Nanomaterials Applications · Electromagnetic wave absorption materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical Science

Dublin City University

Life Sciences Institute

D3 Pharmachemistry, Istituto Italiano di Tecnologia (IIT), via Morego 30, Genova 16163, Italy

Medicinal Chemistry and Technologies for Drug Discovery and Delivery Facility, Istituto Italiano di Tecnologia (IIT), via Morego 30, Genova 16163, Italy

Structural Biophysics Facility, Istituto Italiano di Tecnologia (IIT), via Morego 30, Genova 16163, Italy

L2C, Univ. Montpellier, CNRS

Funding

Science Foundation Ireland · Irish Research Council · Breakthrough Cancer Research

References (70)

Show source-provided references
1. 10.1038/s41392-024-01856-710.1038/s41392-024-01856-7 ↗
2. 10.1016/j.gendis.2022.02.00710.1016/j.gendis.2022.02.007 ↗
3. 10.1002/chem.20230398210.1002/chem.202303982 ↗
4. 10.1039/D4NR05298F10.1039/D4NR05298F ↗
5. 10.1016/j.ijpharm.2020.12011710.1016/j.ijpharm.2020.120117 ↗
6. 10.1016/j.ijpharm.2021.12058610.1016/j.ijpharm.2021.120586 ↗
7. 10.1016/j.addr.2024.11548110.1016/j.addr.2024.115481 ↗
8. 10.1016/j.addr.2023.11482210.1016/j.addr.2023.114822 ↗
9. 10.7150/thno.369210.7150/thno.3692 ↗
10. 10.3390/pharmaceutics1505154510.3390/pharmaceutics15051545 ↗
11. 10.1016/j.jconrel.2015.04.02110.1016/j.jconrel.2015.04.021 ↗
12. 10.1016/j.compositesb.2022.11015010.1016/j.compositesb.2022.110150 ↗
13. 10.1039/D0NR01713B10.1039/D0NR01713B ↗
14. 10.1080/1536383X.2017.130360410.1080/1536383X.2017.1303604 ↗
15. 10.1016/j.jcis.2023.12.16610.1016/j.jcis.2023.12.166 ↗
16. 10.1039/C4NR04533E10.1039/C4NR04533E ↗
17. 10.1002/asia.20060042610.1002/asia.200600426 ↗
18. 10.1021/cm062177j10.1021/cm062177j ↗
19. 10.1039/c3cc39077b10.1039/c3cc39077b ↗
20. 10.1016/j.est.2023.10792810.1016/j.est.2023.107928 ↗
21. 10.1039/C7RA09442F10.1039/C7RA09442F ↗
22. 10.3390/nano712041410.3390/nano7120414 ↗
23. 10.1039/D4NR04990J10.1039/D4NR04990J ↗
24. 10.1016/j.tem.2021.12.00310.1016/j.tem.2021.12.003 ↗
25. 10.1038/nature1232710.1038/nature12327 ↗
26. 10.1021/ar700081510.1021/ar7000815 ↗
27. 10.1016/j.lfs.2021.11952710.1016/j.lfs.2021.119527 ↗
28. 10.3390/cells1204065910.3390/cells12040659 ↗
29. 10.1016/j.jconrel.2012.03.02010.1016/j.jconrel.2012.03.020 ↗
30. 10.3762/bjnano.8.18810.3762/bjnano.8.188 ↗
31. 10.3390/nano908106910.3390/nano9081069 ↗
32. 10.1038/s41592-019-0686-210.1038/s41592-019-0686-2 ↗
33. 10.1038/s41597-023-02898-210.1038/s41597-023-02898-2 ↗
34. 10.18632/oncotarget.1081910.18632/oncotarget.10819 ↗
35. 10.1088/2050-6120/3/4/04400510.1088/2050-6120/3/4/044005 ↗
36. 10.3390/pharmaceutics1112062110.3390/pharmaceutics11120621 ↗
37. 10.1021/acs.biomac.2c0073010.1021/acs.biomac.2c00730 ↗
38. 10.1016/j.actbio.2018.08.00510.1016/j.actbio.2018.08.005 ↗
39. 10.1039/c2cs15344k10.1039/c2cs15344k ↗
40. 10.1021/ja034280510.1021/ja0342805 ↗
41. 10.1021/acsomega.2c0148210.1021/acsomega.2c01482 ↗
42. 10.1016/S0009-2614(02)00557-210.1016/S0009-2614(02)00557-2 ↗
43. 10.1016/B978-0-12-385089-8.00002-910.1016/B978-0-12-385089-8.00002-9 ↗
44. 10.1016/j.biomaterials.2006.08.04910.1016/j.biomaterials.2006.08.049 ↗
45. 10.1617/s11527-017-1059-x10.1617/s11527-017-1059-x ↗
46. 10.1021/ac702589210.1021/ac7025892 ↗
47. 10.1039/c3an36865c10.1039/c3an36865c ↗
48. 10.1366/00037021079121161910.1366/000370210791211619 ↗
49. 10.1016/j.apsadv.2022.10033210.1016/j.apsadv.2022.100332 ↗
50. 10.1111/j.2042-7158.2012.01567.x10.1111/j.2042-7158.2012.01567.x ↗
51. 10.3389/fchem.2020.57800810.3389/fchem.2020.578008 ↗
52. 10.1016/j.carbon.2012.10.02810.1016/j.carbon.2012.10.028 ↗
53. 10.1007/s00604-017-2318-910.1007/s00604-017-2318-9 ↗
54. 10.1016/j.ijpharm.2011.06.01010.1016/j.ijpharm.2011.06.010 ↗
55. 10.1016/j.jphotobiol.2017.03.02410.1016/j.jphotobiol.2017.03.024 ↗
56. 10.1016/j.jddst.2023.10440410.1016/j.jddst.2023.104404 ↗
57. 10.3390/jpm1106057110.3390/jpm11060571 ↗
58. 10.1016/j.colsurfb.2020.11077910.1016/j.colsurfb.2020.110779 ↗
59. 10.3390/nano1301017210.3390/nano13010172 ↗
60. 10.1002/chem.20080164210.1002/chem.200801642 ↗
61. 10.3390/nano1506041510.3390/nano15060415 ↗
62. 10.3390/ijms2405448010.3390/ijms24054480 ↗
63. 10.1016/j.colsurfb.2021.11181910.1016/j.colsurfb.2021.111819 ↗
64. Cell Line - FOLR1 - The Human Protein Atlas https://www.proteinatlas.org/ENSG00000110195-FOLR1/cell+line Accessed 21 September 2025.
65. 10.1126/science.126041910.1126/science.1260419 ↗
66. 10.1186/s12943-024-01967-310.1186/s12943-024-01967-3 ↗
67. 10.1002/smll.20090072510.1002/smll.200900725 ↗
68. 10.1016/j.mam.2023.10120510.1016/j.mam.2023.101205 ↗
69. 10.1016/j.msec.2020.11092810.1016/j.msec.2020.110928 ↗
70. 10.3390/ph1003007210.3390/ph10030072 ↗